SC
TMDX icon

Sapient Capital’s Transmedics TMDX Stock Holding History

Sapient Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,458
Closed -$390K – 437
2025
Q3 		$390K Buy
3,458
+200
+6% +$23.4K 0.01% 284
2025
Q2 		$437K Sell
3,258
-150
-4% -$16.5K 0.01% 263
2025
Q1 		$229K Buy
3,408
+50
+1% +$3.44K ﹤0.01% 336
2024
Q4 		$209K Sell
3,358
-4,546
-58% -$423K ﹤0.01% 348
2024
Q3 		$1.24M Buy
+7,904
New +$1.22M 0.02% 175

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Sapient Capital's TMDX Position: Q4 2025 in Review

Sapient Capital sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 3,458 shares — an estimated $390K sold.

Sapient Capital first reported a position in TMDX in Q3 2024 and held it in 5 quarters. The position peaked at $1.24M in Q3 2024. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Sapient Capital reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Sapient Capital sold 3,458 Transmedics shares in Q4 2025, an estimated $390K.
  • Sapient Capital first reported a position in Transmedics in Q3 2024 and held it in 5 quarters.
  • Sapient Capital's Transmedics position peaked at $1.24M in Q3 2024.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Sapient Capital's 13F filing for Q4 2025, filed 5 Feb 2026.